Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

New HCC Medication: Pembrolizumab

Friday 01 November 2019

We have added a new hepatic indication, hepatocellular carcinoma (HCC). The first drug for this indication, the humanised monoclonal antibody pembrolizumab (Keytruda®), has been added to the checker. A PK factsheet for pembrolizumab is available in the Prescribing Resources. Other medications for HCC will be added to the interaction checker soon.

Awards and commendations
bma-foundation-for-medical-research british-medical-journal-2018 queens_aniversary_prize_2017 rcp-excellence-patient-care-awards-2017 building_better_healthcare_awards_2016